COPD News Today

Phase 3 trial testing benralizumab in COPD patients misses main goal

A Phase 3 clinical trial testing benralizumab as a potential treatment in COPD patients has failed to meet its main goal.
COPD News Today

My experiences with COPD and inflammation aren’t cut-and-dried

Columnist Caroline Gainer experiences relentless fatigue, chills, and sweating, possibly from COPD and/or chronic ...
copdnewstoday

Life Tethered to a Concentrator - a Column by Caroline Gainer

Those of us with chronic obstructive pulmonary disease (COPD) are encouraged to eat an anti-inflammatory diet. I like to think that I harvest my health from a raised bed. I sit on the timbers of my ...
copdnewstoday

Symptoms of COPD

Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder that causes several symptoms which make breathing difficult. These include persistent cough with mucus, wheezing, and shortness ...
copdnewstoday

Approved Treatments for COPD

Although there is no cure for COPD yet, there are several approved treatments that can help manage the disease and ease symptoms. Learn more about some of the specific therapies used to treat this ...
copdnewstoday

Depression and Anxiety Common, Not Likely to Affect COPD’s Course

Depression and anxiety are highly prevalent in people with chronic obstructive pulmonary disease (COPD) a study of patients in Spain reported, with depression linked to a greater risk of a repeat ...
copdnewstoday

FDA approves first RSV vaccine for at-risk adults younger than 50

The U.S. Food and Drug Administration (FDA) has approved Abrysvo, a vaccine that protects against lung infections caused by the respiratory syncytial virus — commonly known as RSV — for adults as ...
copdnewstoday

DirectRx pharmacy distributing COPD therapy Ohtuvayre in US

DirectRx, a specialty pharmacy for people with chronic health disorders, is now part of the exclusive U.S. pharmacy network distributing Ohtuvayre (ensifentrine), a newly approved therapy for chronic ...
copdnewstoday

Formoterol for COPD

Formoterol (brand names Perforomist, Foradil) is a bronchodilator in a class of medications called long-acting beta agonists (LABAs). It is used to control wheezing, shortness of breath, coughing and ...
copdnewstoday

4 reasons I benefited from changing up my exercise routine with COPD

When I was diagnosed with chronic obstructive pulmonary disease (COPD) in 2013, my first emotion was relief. I had a diagnosis; the feeling that I was slowly deteriorating was not just in my head. I ...
copdnewstoday

Experimental Treatments for COPD

Researchers continue to study ways to better manage the symptoms of COPD. There are several experimental therapies currently being tested in clinical trials for the disease. Learn more about some of ...